Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Design Therapeutics Inc (DSGN)

Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Design Therapeutics Inc 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 USA

www.designtx.com Employees: 54 P: 858-293-4900

Sector:

Medical

Description:

Design Therapeutics Inc. is a biotechnology company. It involved in developing a platform of gene targeted chimera small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions. Design Therapeutics Inc. is based in CARLSBAD, Calif.

Key Statistics

Overview:

Market Capitalization, $K 534,322
Enterprise Value, $K 511,762
Shares Outstanding, K 56,964
Annual Sales, $ 0 K
Annual Net Income, $ -49,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -17,000 K
EBIT, $ -77,990 K
EBITDA, $ -83,590 K
60-Month Beta 1.63
% of Insider Shareholders 23.50%
% of Institutional Shareholders 56.64%
Float, K 43,577
% Float 76.50%
Short Interest 2,120
Short Float 3.72%
Short Volume Ratio 0.56

Growth:

1-Year Return 47.97%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.30 on 11/05/25
Next Earnings Date 03/09/26
Earnings Per Share ttm -1.19
EPS Growth vs. Prev Qtr 11.76%
EPS Growth vs. Prev Year -30.43%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

DSGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -30.56%
Return-on-Assets % -29.19%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.79
Book Value/Share 3.51
Interest Coverage -1.75
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar